600479 千金药业
已收盘 10-31 15:00:00
资讯
新帖
简况
图解千金药业三季报:第三季度单季净利润同比增长18.42%
证券之星 · 10-29 12:25
图解千金药业三季报:第三季度单季净利润同比增长18.42%
千金药业最新公告:子公司千金湘江药业获得富马酸伏诺拉生片与恩格列净片药品注册证书
证券之星 · 10-13
千金药业最新公告:子公司千金湘江药业获得富马酸伏诺拉生片与恩格列净片药品注册证书
每周股票复盘:千金药业(600479)收购两子公司股权
证券之星 · 09-27
每周股票复盘:千金药业(600479)收购两子公司股权
每周股票复盘:千金药业(600479)完成收购两子公司股权过户
证券之星 · 09-20
每周股票复盘:千金药业(600479)完成收购两子公司股权过户
千金药业(600479)披露发行股份及支付现金购买资产之标的资产过户完成公告,9月17日股价下跌1.1%
证券之星 · 09-17
千金药业(600479)披露发行股份及支付现金购买资产之标的资产过户完成公告,9月17日股价下跌1.1%
每周股票复盘:千金药业(600479)并购获证监会注册批复
证券之星 · 09-13
每周股票复盘:千金药业(600479)并购获证监会注册批复
千金药业(600479)披露收购报告书半年度持续督导公告,9月11日股价上涨1.45%
证券之星 · 09-11
千金药业(600479)披露收购报告书半年度持续督导公告,9月11日股价上涨1.45%
千金药业(600479)2025年中报简析:净利润同比增长8.5%,盈利能力上升
证券之星 · 08-30
千金药业(600479)2025年中报简析:净利润同比增长8.5%,盈利能力上升
图解千金药业中报:第二季度单季净利润同比增长4.26%
证券之星 · 08-29
图解千金药业中报:第二季度单季净利润同比增长4.26%
千金药业(600479)6月30日股东户数4.09万户,较上期减少4.16%
证券之星 · 08-29
千金药业(600479)6月30日股东户数4.09万户,较上期减少4.16%
每周股票复盘:千金药业(600479)并购重组审核会议安排
证券之星 · 08-16
每周股票复盘:千金药业(600479)并购重组审核会议安排
千金药业:上交所并购重组审核委员会于8月18日召开审议会议
格隆汇 · 08-12
千金药业:上交所并购重组审核委员会于8月18日召开审议会议
2025年上半年湖南省工业企业有21242个,同比下降0.99%
智研咨询 · 08-12
2025年上半年湖南省工业企业有21242个,同比下降0.99%
千金药业:拟购千金湘江药业28.92%股权及千金协力药业68%股权
公司公告 · 08-07
千金药业:拟购千金湘江药业28.92%股权及千金协力药业68%股权
医药上市公司财务总监PK:盘龙药业祝凤鸣凭中职学历拿下56.94万年薪 62岁已于公司任职15年
新浪证券 · 08-01
医药上市公司财务总监PK:盘龙药业祝凤鸣凭中职学历拿下56.94万年薪 62岁已于公司任职15年
中证医药卫生红利指数报16509.94点,前十大权重包含明德生物等
金融界 · 07-31
中证医药卫生红利指数报16509.94点,前十大权重包含明德生物等
药界周刊(2025.7.22—7.28)
金花股份 · 07-28
药界周刊(2025.7.22—7.28)
千金药业:公司目前有5个创新药在研,其中3个中药1类新药
互动易 · 07-25
千金药业:公司目前有5个创新药在研,其中3个中药1类新药
千金药业:公司参投的两支基金目前运营正常
证券之星 · 07-25
千金药业:公司参投的两支基金目前运营正常
千金药业:子公司获得药品注册证书
格隆汇 · 07-23
千金药业:子公司获得药品注册证书
加载更多
公司概况
公司名称:
株洲千金药业股份有限公司
所属行业:
医药制造业
上市日期:
2004-03-12
主营业务:
株洲千金药业股份有限公司的主营业务是中成药、化学药、女性卫生用品的研发、生产和销售,以及药品的批发和零售业务。公司的主要产品是妇科千金片(胶囊)、补血益母丸(颗粒)、缬沙坦胶囊、马来酸依那普利片、盐酸地芬尼多片、水飞蓟宾葡甲胺片、苯磺酸氨氣地平片、非那雄胺片以及妇科专用棉巾系列等。公司连续十多年保持口服妇科炎症中成药市场第一品牌地位。“千金”是国家驰名商标。千金药业荣获“2025中国中药研发实力前50强”“2025大健康产业影响力品牌”等奖项。
发行价格:
23.05
{"stockData":{"symbol":"600479","market":"SH","secType":"STK","nameCN":"千金药业","latestPrice":10.63,"timestamp":1761894001000,"preClose":10.56,"halted":0,"volume":6340682,"delay":0,"changeRate":0.0066,"floatShares":419000000,"shares":492000000,"eps":0.508,"marketStatus":"已收盘","change":0.07,"latestTime":"10-31 15:00:00","open":10.5,"high":10.67,"low":10.5,"amount":67270700,"amplitude":0.0161,"askPrice":10.63,"askSize":102,"bidPrice":10.62,"bidSize":244,"shortable":0,"etf":0,"ttmEps":0.508,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1762133400000},"marketStatusCode":5,"adr":0,"adjPreClose":10.56,"symbolType":"stock","openAndCloseTimeList":[[1761874200000,1761881400000],[1761886800000,1761894000000]],"highLimit":11.62,"lowLimit":9.5,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":492210016,"isCdr":false,"pbRate":2.09,"roa":"--","peRate":20.925197,"roe":"7.53%","epsLYR":0.5579,"committee":-0.387937,"marketValue":5232000000,"turnoverRate":0.0152,"status":0,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2025-11-03。","floatMarketCap":4449000000},"requestUrl":"/m/hq/s/600479","defaultTab":"news","newsList":[{"id":"2579304905","title":"图解千金药业三季报:第三季度单季净利润同比增长18.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579304905","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579304905?lang=zh_cn&edition=full","pubTime":"2025-10-29 20:25","pubTimestamp":1761740757,"startTime":"0","endTime":"0","summary":"证券之星消息,千金药业2025年三季报显示,前三季度公司主营收入27.18亿元,同比上升0.14%;归母净利润1.87亿元,同比上升11.47%;扣非净利润1.7亿元,同比上升4.74%;其中2025年第三季度,公司单季度主营收入9.0亿元,同比上升13.91%;单季度归母净利润5963.0万元,同比上升18.42%;单季度扣非净利润5174.04万元,同比上升0.79%;负债率33.8%,投资收益4244.26万元,财务费用-1381.52万元,毛利率49.87%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900041585.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600479"],"gpt_icon":0},{"id":"2575472006","title":"千金药业最新公告:子公司千金湘江药业获得富马酸伏诺拉生片与恩格列净片药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2575472006","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575472006?lang=zh_cn&edition=full","pubTime":"2025-10-13 18:20","pubTimestamp":1760350808,"startTime":"0","endTime":"0","summary":"千金药业(600479.SH)公告称,公司下属子公司千金湘江药业近日收到国家药品监督管理局核准签发的富马酸伏诺拉生片(20mg、10mg)与恩格列净片(10mg、25mg)的《药品注册证书》。其中,富马酸伏诺拉生片适用于反流性食管炎,国内销售总额在2025年半年度为5.32亿元;恩格列净片是一种高选择性钠-葡萄糖协同转运蛋白2抑制剂,国内销售总额在2025年半年度为5.95亿元。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101300021316.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600479","BK0239","BK0186"],"gpt_icon":0},{"id":"2570437894","title":"每周股票复盘:千金药业(600479)收购两子公司股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2570437894","media":"证券之星","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570437894?lang=zh_cn&edition=full","pubTime":"2025-09-28 03:59","pubTimestamp":1759003178,"startTime":"0","endTime":"0","summary":"截至2025年9月26日收盘,千金药业报收于10.37元,较上周的10.53元下跌1.52%。本周,千金药业9月22日盘中最高价报10.57元。本周关注点来自公司公告汇总:千金药业拟发行股份及支付现金购买千金湘江药业28.92%股权和千金协力药业68.00%股权,合计作价62,346.69万元。标的公司采用收益法评估,千金湘江药业股东全部权益评估值为124,670.00万元,千金协力药业为38,671.00万元。交易完成后,上市公司对千金湘江药业持股比例将提升至79.92%,对千金协力药业实现100%控股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092800001001.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600479","BK0186","BK0239"],"gpt_icon":0},{"id":"2569455602","title":"每周股票复盘:千金药业(600479)完成收购两子公司股权过户","url":"https://stock-news.laohu8.com/highlight/detail?id=2569455602","media":"证券之星","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569455602?lang=zh_cn&edition=full","pubTime":"2025-09-21 02:59","pubTimestamp":1758394748,"startTime":"0","endTime":"0","summary":"截至2025年9月19日收盘,千金药业报收于10.53元,较上周的10.96元下跌3.92%。本周关注点来自公司公告汇总:千金药业已合法取得千金湘江药业28.92%股权和千金协力药业68.00%股权,资产过户手续办理完毕。交易完成后,千金药业将持有千金湘江药业79.92%股权,千金协力药业将成为其全资子公司。标的资产已在核查意见出具日前完成过户至上市公司名下。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092100000613.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0186","600479"],"gpt_icon":0},{"id":"2568922564","title":"千金药业(600479)披露发行股份及支付现金购买资产之标的资产过户完成公告,9月17日股价下跌1.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568922564","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568922564?lang=zh_cn&edition=full","pubTime":"2025-09-17 22:32","pubTimestamp":1758119544,"startTime":"0","endTime":"0","summary":"近日,千金药业发布关于发行股份及支付现金购买资产暨关联交易之标的资产过户情况的公告。公告显示,公司已于2025年9月12日收到中国证监会批复,同意其发行股份及支付现金购买资产的注册申请。截至公告披露日,本次交易涉及的标的资产过户手续已办理完毕。独立财务顾问和法律顾问均认为,本次交易实施过程合法合规,标的资产过户合法有效,后续事项的实施不存在实质性障碍。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091700040511.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","600479","BK0186"],"gpt_icon":0},{"id":"2567136765","title":"每周股票复盘:千金药业(600479)并购获证监会注册批复","url":"https://stock-news.laohu8.com/highlight/detail?id=2567136765","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567136765?lang=zh_cn&edition=full","pubTime":"2025-09-14 05:20","pubTimestamp":1757798428,"startTime":"0","endTime":"0","summary":"截至2025年9月12日收盘,千金药业报收于10.96元,较上周的10.92元上涨0.37%。本周关注点公司公告汇总:千金药业发行股份购买资产获证监会同意注册批复公司公告汇总:收购报告书持续督导期内收购人无重大调整计划公司公告汇总国泰海通证券股份有限公司作为财务顾问,对株洲千金药业股份有限公司收购报告书出具2025年半年度持续督导意见。截至2025年8月30日,交易已取得上交所审核通过,尚需中国证监会注册后办理过户。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091400001281.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600479","BK0239","BK0186"],"gpt_icon":0},{"id":"2566949709","title":"千金药业(600479)披露收购报告书半年度持续督导公告,9月11日股价上涨1.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2566949709","media":"证券之星","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566949709?lang=zh_cn&edition=full","pubTime":"2025-09-11 22:28","pubTimestamp":1757600904,"startTime":"0","endTime":"0","summary":"截至2025年9月11日收盘,千金药业报收于11.23元,较前一交易日上涨1.45%,最新总市值为47亿元。该股当日开盘11.04元,最高11.23元,最低10.85元,成交额达1.42亿元,换手率为3.05%。近日,国泰海通证券股份有限公司发布了关于株洲千金药业股份有限公司收购报告书之2025年半年度持续督导意见。财务顾问认为,收购人及其一致行动人依法合规运作,持续督导期内未发生违反相关规定的行为。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091100038919.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0186","600479"],"gpt_icon":0},{"id":"2563880611","title":"千金药业(600479)2025年中报简析:净利润同比增长8.5%,盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2563880611","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563880611?lang=zh_cn&edition=full","pubTime":"2025-08-31 06:05","pubTimestamp":1756591519,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期千金药业发布2025年中报。截至本报告期末,公司营业总收入18.18亿元,同比下降5.52%,归母净利润1.28亿元,同比上升8.5%。按单季度数据看,第二季度营业总收入8.13亿元,同比下降11.97%,第二季度归母净利润7456.98万元,同比上升4.26%。本报告期千金药业盈利能力上升,毛利率同比增幅10.63%,净利率同比增幅23.57%。去年的净利率为8.34%,算上全部成本后,公司产品或服务的附加值一般。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025083100001121.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600479"],"gpt_icon":0},{"id":"2563047877","title":"图解千金药业中报:第二季度单季净利润同比增长4.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2563047877","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563047877?lang=zh_cn&edition=full","pubTime":"2025-08-29 19:14","pubTimestamp":1756466092,"startTime":"0","endTime":"0","summary":"证券之星消息,千金药业2025年中报显示,公司主营收入18.18亿元,同比下降5.52%;归母净利润1.28亿元,同比上升8.5%;扣非净利润1.18亿元,同比上升6.58%;其中2025年第二季度,公司单季度主营收入8.13亿元,同比下降11.97%;单季度归母净利润7456.98万元,同比上升4.26%;单季度扣非净利润7013.62万元,同比上升4.5%;负债率33.63%,投资收益1880.36万元,财务费用-479.19万元,毛利率49.97%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082900038165.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600479"],"gpt_icon":0},{"id":"2563048757","title":"千金药业(600479)6月30日股东户数4.09万户,较上期减少4.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2563048757","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563048757?lang=zh_cn&edition=full","pubTime":"2025-08-29 17:17","pubTimestamp":1756459046,"startTime":"0","endTime":"0","summary":"证券之星消息,近日千金药业披露,截至2025年6月30日公司股东户数为4.09万户,较3月31日减少1774.0户,减幅为4.16%。在中药行业个股中,千金药业股东户数低于行业平均水平,截至6月30日,中药行业平均股东户数为5.31万户。从股价来看,2025年3月31日至2025年6月30日,千金药业区间涨幅为2.36%,在此期间股东户数减少1774.0户,减幅为4.16%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082900031978.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0186","600479"],"gpt_icon":0},{"id":"2560926116","title":"每周股票复盘:千金药业(600479)并购重组审核会议安排","url":"https://stock-news.laohu8.com/highlight/detail?id=2560926116","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560926116?lang=zh_cn&edition=full","pubTime":"2025-08-17 06:26","pubTimestamp":1755383175,"startTime":"0","endTime":"0","summary":"截至2025年8月15日收盘,千金药业报收于11.04元,较上周的11.04元上涨0.0%。本周,千金药业8月12日盘中最高价报11.14元。本周关注点公司公告汇总: 千金药业并购重组审核会议将于2025年8月18日召开公司公告汇总株洲千金药业股份有限公司计划通过发行股份及支付现金的方式购买湖南千金湘江药业股份有限公司28.92%的股权及湖南千金协力药业有限公司68.00%的股权。上海证券交易所并购重组审核委员会定于2025年8月18日召开会议,审议此次交易。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081700001313.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600479","BK0186","BK0239","161123"],"gpt_icon":0},{"id":"2558160614","title":"千金药业:上交所并购重组审核委员会于8月18日召开审议会议","url":"https://stock-news.laohu8.com/highlight/detail?id=2558160614","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558160614?lang=zh_cn&edition=full","pubTime":"2025-08-12 15:38","pubTimestamp":1754984315,"startTime":"0","endTime":"0","summary":"格隆汇8月12日丨千金药业(600479.SH)公布,根据上海证券交易所(以下简称“上交所”)并购重组审核委员会公告的《上海证券交易所并购重组审核委员会2025年第12次审议会议公告》,上交所并购重组审核委员会定于2025年8月18日召开2025年第12次并购重组审核委员会审议会议,审核公司本次交易的申请。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081215393497428918&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081215393497428918&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["161123","BK0239","BK0186","600479"],"gpt_icon":0},{"id":"2558111690","title":"2025年上半年湖南省工业企业有21242个,同比下降0.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558111690","media":"智研咨询","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558111690?lang=zh_cn&edition=full","pubTime":"2025-08-12 11:21","pubTimestamp":1754968860,"startTime":"0","endTime":"0","summary":"上市公司:株冶集团,新威凌,岳阳兴长,克明食品,盐津铺子,劲仔食品,绝味食品,华升股份,千金药业,方盛制药,泰嘉股份,宇环数控,宇晶股份,三德科技,岱勒新材,华锐精密相关报告:智研咨询发布的《2025-2031年中国工业云行业市场深度评估及投资机会预测报告》2025年上半年,湖南省工业企业数为21242个,和上年同期相比,减少了212个,同比下降0.99%,占全国的比重为4.08%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081211212194ddf5ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081211212194ddf5ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600961","603998","BK0010","600479","BK0233","688059","600156","603517"],"gpt_icon":0},{"id":"2557556326","title":"千金药业:拟购千金湘江药业28.92%股权及千金协力药业68%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2557556326","media":"公司公告","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557556326?lang=zh_cn&edition=full","pubTime":"2025-08-07 17:30","pubTimestamp":1754559020,"startTime":"0","endTime":"0","summary":"千金药业公告,拟通过发行股份及支付现金方式购买湖南千金湘江药业28.92%股权及湖南千金协力药业68%股权。公司根据上海证券交易所审核意见修订并披露了交易报告书(草案)(上会稿),更新了包括发行价格、数量、标的资产评估情况等多方面内容,并补充完善了交易对方信息及标的公司相关财务分析。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080717424594d550e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080717424594d550e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600479","BK0239","BK0186"],"gpt_icon":0},{"id":"2556386617","title":"医药上市公司财务总监PK:盘龙药业祝凤鸣凭中职学历拿下56.94万年薪 62岁已于公司任职15年","url":"https://stock-news.laohu8.com/highlight/detail?id=2556386617","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556386617?lang=zh_cn&edition=full","pubTime":"2025-08-01 12:20","pubTimestamp":1754022009,"startTime":"0","endTime":"0","summary":"新浪财经《2024年度A股CFO数据报告》显示,2024年A股上市公司财务总监CFO群体薪酬规模合计达42.70亿元,平均年薪为81.48万元。其中,赵洁于2024年4月担任*ST四环CFO,后于今年6月离职。数据显示,赵洁2024年年薪仅23.1万元,显著低于行业平均水平。其中,除迈瑞医疗的赵云之外,其余三名CFO均在公司兼任其他职务。具体而言,吕洪斌同时兼任迪哲医药董事会秘书;司燕霞同时兼任丽珠集团副总经理;沈波同时兼任上海医药董事、总经理。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801122019972be4c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801122019972be4c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600479","601607","688192","BK4218","02607","PK","SHPMY","BK4181","BK4175"],"gpt_icon":0},{"id":"2555888141","title":"中证医药卫生红利指数报16509.94点,前十大权重包含明德生物等","url":"https://stock-news.laohu8.com/highlight/detail?id=2555888141","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555888141?lang=zh_cn&edition=full","pubTime":"2025-07-31 16:19","pubTimestamp":1753949998,"startTime":"0","endTime":"0","summary":"金融界7月31日消息,上证指数低开低走,中证医药卫生红利指数 报16509.94点。数据统计显示,中证医药卫生红利指数近一个月上涨12.87%,近三个月上涨19.55%,年至今上涨13.27%。从中证医药卫生红利指数持仓的市场板块来看,上海证券交易所占比50.82%、深圳证券交易所占比49.18%。从中证医药卫生红利指数持仓样本的行业来看,中药占比34.45%、化学药占比25.27%、医疗商业与服务占比16.54%、医疗器械占比13.84%、生物药品占比7.89%、制药与生物科技服务占比2.01%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507311637239729a8ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507311637239729a8ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600479","603367","BK0188","BK0239","399933","BK0070","000933.SH","600329","688658","BK0077","000015.SH","002932","600285"],"gpt_icon":0},{"id":"2554477463","title":"药界周刊(2025.7.22—7.28)","url":"https://stock-news.laohu8.com/highlight/detail?id=2554477463","media":"金花股份","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554477463?lang=zh_cn&edition=full","pubTime":"2025-07-28 19:18","pubTimestamp":1753701492,"startTime":"0","endTime":"0","summary":"2025.7.22-2025.7.28药界周刊药界风云 热点速览#国内动保mRNA疫苗进入临床井喷期##我国儿童化妆品步入发展快车道#一、行业动态01世卫组织警示基孔肯雅热疫情风险近日,基孔肯雅热在国内外引发广泛关注。世界卫生组织25日警告,基孔肯雅热病毒正在全球多地扩散,已有119个国家报告病例,约550万人面临感染风险。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728205724a6c607a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728205724a6c607a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0405327494.USD","BK0012","BK0188","LU1064130708.USD","688133","02453","LU1655091616.SGD","LU1064131003.USD","LU2328871848.SGD","LU2148510915.USD","BK0196","LU1997245177.USD","600276","LU1969619763.USD","BK0028","LU2495084118.USD","600479","BK0239","LU1997244956.HKD","LU0405327148.USD","BK0183","LU1997245094.SGD","BK0060","LU2488822045.USD","01276","LU1328615791.USD","01061"],"gpt_icon":0},{"id":"2554752116","title":"千金药业:公司目前有5个创新药在研,其中3个中药1类新药","url":"https://stock-news.laohu8.com/highlight/detail?id=2554752116","media":"互动易","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554752116?lang=zh_cn&edition=full","pubTime":"2025-07-25 15:54","pubTimestamp":1753430041,"startTime":"0","endTime":"0","summary":"有投资者向千金药业提问, 近期创新药板块市场表现不错?贵司年报显示25年加大研发,目前贵司创新药进展如何?公司回答表示,感谢关注。公司目前有5个创新药在研,其中3个中药1类新药:1个已进入临床阶段,2个处于药学研究阶段,2个化药创新药均处于化合物筛选阶段。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725160902a6c13d7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725160902a6c13d7a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600479","BK0186","159992","561510","BK0239","562390"],"gpt_icon":0},{"id":"2554754294","title":"千金药业:公司参投的两支基金目前运营正常","url":"https://stock-news.laohu8.com/highlight/detail?id=2554754294","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554754294?lang=zh_cn&edition=full","pubTime":"2025-07-25 15:51","pubTimestamp":1753429881,"startTime":"0","endTime":"0","summary":"证券之星消息,XD千金药(600479)07月25日在投资者关系平台上答复投资者关心的问题。投资者提问:贵司主要投资了2个基金,分别是株洲市国海国创千金医药创业投资合伙企业(有限合伙)和株洲市先进产业集群发展母基金合伙企业(有限合伙),投资时间已经5年和3年,为什么很少披露投资情况?目前有没有新进展?贵司是否间接持有脑再生科技公司股份?XD千金药回复:感谢关注。公司已按照相关法律法规的要求进行了披露。公司参投的两支基金目前运营正常,暂无应披露而未披露事项。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072500022441.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0186","600479"],"gpt_icon":0},{"id":"2553321636","title":"千金药业:子公司获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2553321636","media":"格隆汇","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553321636?lang=zh_cn&edition=full","pubTime":"2025-07-23 17:36","pubTimestamp":1753263362,"startTime":"0","endTime":"0","summary":"格隆汇7月23日丨千金药业公布,近日,公司下属子公司湖南千金湘江药业股份有限公司收到国家药品监督管理局核准签发的腺苷钴胺胶囊《药品注册证书》,公司下属子公司湖南千金协力药业有限公司收到国家药品监督管理局核准签发的沙库巴曲缬沙坦钠片《药品注册证书》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723173630954e734a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723173630954e734a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0186","BK0239","600479"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1761931832204,"stockEarnings":[{"period":"1week","weight":-0.0037},{"period":"1month","weight":0.031},{"period":"3month","weight":-0.056},{"period":"6month","weight":0.0695},{"period":"1year","weight":0.0304},{"period":"ytd","weight":0.0284}],"compareEarnings":[{"period":"1week","weight":0.0011},{"period":"1month","weight":0.0185},{"period":"3month","weight":0.1109},{"period":"6month","weight":0.2061},{"period":"1year","weight":0.2058},{"period":"ytd","weight":0.1799}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"株洲千金药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"36839人(较上一季度减少9.85%)","perCapita":"11360股","listingDate":"2004-03-12","address":"湖南省株洲市天元区株洲大道801号","registeredCapital":"49221万元","survey":" 株洲千金药业股份有限公司的主营业务是中成药、化学药、女性卫生用品的研发、生产和销售,以及药品的批发和零售业务。公司的主要产品是妇科千金片(胶囊)、补血益母丸(颗粒)、缬沙坦胶囊、马来酸依那普利片、盐酸地芬尼多片、水飞蓟宾葡甲胺片、苯磺酸氨氣地平片、非那雄胺片以及妇科专用棉巾系列等。公司连续十多年保持口服妇科炎症中成药市场第一品牌地位。“千金”是国家驰名商标。千金药业荣获“2025中国中药研发实力前50强”“2025大健康产业影响力品牌”等奖项。","listedPrice":23.05},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.5","shortVersion":"4.35.5","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"千金药业(600479)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供千金药业(600479)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"千金药业,600479,千金药业股票,千金药业股票老虎,千金药业股票老虎国际,千金药业行情,千金药业股票行情,千金药业股价,千金药业股市,千金药业股票价格,千金药业股票交易,千金药业股票购买,千金药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"千金药业(600479)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供千金药业(600479)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}